Global Cell & Gene Therapy Clinical Trial Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Cell & Gene Therapy Clinical Trial Services Market is presumed to reach the market size of nearly USD 11.89 Billion by 2032 from USD 4.53 Billion in 2023 with a CAGR of 11.32% under the study period 2024-2032.

Cell and gene therapy clinical trial services support developing and testing innovative treatments that entail modifying genes or cells to manage or prevent diseases. These services encompass a variety of activities, including patient recruitment, regulatory compliance, manufacturing of therapeutic agents, and clinical trial management. They are crucial in translating scientific breakthroughs into viable therapies by ensuring trials are conducted safely, ethically, and efficiently. Providers of these services work closely with researchers, pharmaceutical companies, and healthcare institutions to navigate the complex landscape of cell and gene therapy trials, ultimately aiming to bring new, life-saving treatments to market.

MARKET DYNAMICS

The surge in research and development activities and the growing demand for innovative treatment options have propelled the demand for cell and gene therapy clinical trial services. Companies & academic institutions are spending heavily in advancing these groundbreaking therapies, leading to an upsurge in clinical trials worldwide. The spurring prevalence of genetic disorders & chronic diseases further underscores the urgency for effective cell and gene therapies, driving the need for comprehensive clinical trial services to support their development. The potential of cell & gene transformation to revolutionize healthcare persists, driving sustained interest and investment in clinical research. Collaborations between industry stakeholders, regulatory bodies, and research institutions are crucial for advancing cell and gene therapy clinical trial services. However, stringent regulatory requirements and complex ethical considerations may challenge the growth of the cell and gene therapy clinical trial services market in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cell & Gene Therapy Clinical Trial Services. The growth and trends of Cell & Gene Therapy Clinical Trial Services industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cell & Gene Therapy Clinical Trial Services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service

Clinical Trial Design & Planning
Supply & Logistics Services
Regulatory Affairs & Compliance
Data Management & Biostatistics
Site Management & Monitoring
Other Services

By Phase

Phase I
Phase II
Phase III
Phase IV

By Indication

Oncology
Hematology
Endocrine/metabolic Disorders
Infectious Diseases
Neurology
Cardiovascular Diseases
Musculoskeletal Disorders
Other indications

By Therapy Type

Gene Therapy
Cell Therapy
Gene Modified Cell Therapy

By End-Use

Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Academic & Research Institutes
Other end-users

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cell & Gene Therapy Clinical Trial Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell & Gene Therapy Clinical Trial Services market include Advarra, Charles River Laboratories International Inc., Catalent Pharma, ICON PLC, IQVIA, Medpace Inc., Novotech, Precision Medicine Group LLC, Parexel International, Syneos Health, Sharp Services LLC, Thermo Fisher Scientific Inc., Worldwide Clinical Trials. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112114672

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CELL & GENE THERAPY CLINICAL TRIAL SERVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Service
- 3.7.2 Market Attractiveness Analysis By Phase
- 3.7.3 Market Attractiveness Analysis By Indication
- 3.7.4 Market Attractiveness Analysis By Therapy Type
- 3.7.5 Market Attractiveness Analysis By End-Use
- 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CELL & GENE THERAPY CLINICAL TRIAL SERVICES MARKET ANALYSIS BY SERVICE

5.1. Overview By Service
5.2. Historical and Forecast Data
5.3. Analysis By Service
5.4. Clinical Trial Design & Planning Historic and Forecast Sales By Regions
5.5. Supply & Logistics Services Historic and Forecast Sales By Regions
5.6. Regulatory Affairs & Compliance Historic and Forecast Sales By Regions
5.7. Data Management & Biostatistics Historic and Forecast Sales By Regions
5.8. Site Management & Monitoring Historic and Forecast Sales By Regions
5.9. Other Services Historic and Forecast Sales By Regions

6. GLOBAL CELL & GENE THERAPY CLINICAL TRIAL SERVICES MARKET ANALYSIS BY PHASE

6.1. Overview By Phase
6.2. Historical and Forecast Data
6.3. Analysis By Phase
6.4. Phase I Historic and Forecast Sales By Regions
6.5. Phase II Historic and Forecast Sales By Regions
6.6. Phase III Historic and Forecast Sales By Regions
6.7. Phase IV Historic and Forecast Sales By Regions

7. GLOBAL CELL & GENE THERAPY CLINICAL TRIAL SERVICES MARKET ANALYSIS BY INDICATION

7.1. Overview By Indication
7.2. Historical and Forecast Data
7.3. Analysis By Indication
7.4. Oncology Historic and Forecast Sales By Regions
7.5. Hematology Historic and Forecast Sales By Regions
7.6. Endocrine/metabolic Disorders Historic and Forecast Sales By Regions
7.7. Infectious Diseases Historic and Forecast Sales By Regions
7.8. Neurology Historic and Forecast Sales By Regions
7.9. Cardiovascular Diseases Historic and Forecast Sales By Regions
7.10. Musculoskeletal Disorders Historic and Forecast Sales By Regions
7.11. Other indications Historic and Forecast Sales By Regions

8. GLOBAL CELL & GENE THERAPY CLINICAL TRIAL SERVICES MARKET ANALYSIS BY THERAPY TYPE

8.1. Overview By Therapy Type
8.2. Historical and Forecast Data
8.3. Analysis By Therapy Type
8.4. Gene Therapy Historic and Forecast Sales By Regions
8.5. Cell Therapy Historic and Forecast Sales By Regions
8.6. Gene Modified Cell Therapy Historic and Forecast Sales By Regions

9. GLOBAL CELL & GENE THERAPY CLINICAL TRIAL SERVICES MARKET ANALYSIS BY END-USE

9.1. Overview By End-Use
9.2. Historical and Forecast Data
9.3. Analysis By End-Use
9.4. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
9.5. Contract Research Organizations Historic and Forecast Sales By Regions
9.6. Academic & Research Institutes Historic and Forecast Sales By Regions
9.7. Other end-users Historic and Forecast Sales By Regions

10. GLOBAL CELL & GENE THERAPY CLINICAL TRIAL SERVICES MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1 Overview, Historic and Forecast Data Sales Analysis
- 10.3.2 North America By Segment Sales Analysis
- 10.3.3 North America By Country Sales Analysis
- 10.3.4 United States Sales Analysis
- 10.3.5 Canada Sales Analysis
- 10.3.6 Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1 Overview, Historic and Forecast Data Sales Analysis
- 10.4.2 Europe By Segment Sales Analysis
- 10.4.3 Europe By Country Sales Analysis
- 10.4.4 United Kingdom Sales Analysis
- 10.4.5 France Sales Analysis
- 10.4.6 Germany Sales Analysis
- 10.4.7 Italy Sales Analysis
- 10.4.8 Russia Sales Analysis
- 10.4.9 Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1 Overview, Historic and Forecast Data Sales Analysis
- 10.5.2 Asia Pacific By Segment Sales Analysis
- 10.5.3 Asia Pacific By Country Sales Analysis
- 10.5.4 China Sales Analysis
- 10.5.5 India Sales Analysis
- 10.5.6 Japan Sales Analysis
- 10.5.7 South Korea Sales Analysis
- 10.5.8 Australia Sales Analysis
- 10.5.9 South East Asia Sales Analysis
- 10.5.10 Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1 Overview, Historic and Forecast Data Sales Analysis
- 10.6.2 Latin America By Segment Sales Analysis
- 10.6.3 Latin America By Country Sales Analysis
- 10.6.4 Brazil Sales Analysis
- 10.6.5 Argentina Sales Analysis
- 10.6.6 Peru Sales Analysis
- 10.6.7 Chile Sales Analysis
- 10.6.8 Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1 Overview, Historic and Forecast Data Sales Analysis
- 10.7.2 Middle East & Africa By Segment Sales Analysis
- 10.7.3 Middle East & Africa By Country Sales Analysis
- 10.7.4 Saudi Arabia Sales Analysis
- 10.7.5 UAE Sales Analysis
- 10.7.6 Israel Sales Analysis
- 10.7.7 South Africa Sales Analysis
- 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE CELL & GENE THERAPY CLINICAL TRIAL SERVICES COMPANIES

11.1. Cell & Gene Therapy Clinical Trial Services Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12. COMPANY PROFILES OF CELL & GENE THERAPY CLINICAL TRIAL SERVICES INDUSTRY

12.1. Top Companies Market Share Analysis
12.2. Market Concentration Rate
12.3. Advarra
- 12.3.1 Company Overview
- 12.3.2 Company Revenue
- 12.3.3 Products
- 12.3.4 Recent Developments
12.4. Charles River Laboratories International Inc.
- 12.4.1 Company Overview
- 12.4.2 Company Revenue
- 12.4.3 Products
- 12.4.4 Recent Developments
12.5. Catalent Pharma
- 12.5.1 Company Overview
- 12.5.2 Company Revenue
- 12.5.3 Products
- 12.5.4 Recent Developments
12.6. ICON PLC
- 12.6.1 Company Overview
- 12.6.2 Company Revenue
- 12.6.3 Products
- 12.6.4 Recent Developments
12.7. IQVIA
- 12.7.1 Company Overview
- 12.7.2 Company Revenue
- 12.7.3 Products
- 12.7.4 Recent Developments
12.8. Medpace Inc.
- 12.8.1 Company Overview
- 12.8.2 Company Revenue
- 12.8.3 Products
- 12.8.4 Recent Developments
12.9. Novotech
- 12.9.1 Company Overview
- 12.9.2 Company Revenue
- 12.9.3 Products
- 12.9.4 Recent Developments
12.10. Precision Medicine Group LLC
- 12.10.1 Company Overview
- 12.10.2 Company Revenue
- 12.10.3 Products
- 12.10.4 Recent Developments
12.11. Parexel International
- 12.11.1 Company Overview
- 12.11.2 Company Revenue
- 12.11.3 Products
- 12.11.4 Recent Developments
12.12. Syneos Health
- 12.12.1 Company Overview
- 12.12.2 Company Revenue
- 12.12.3 Products
- 12.12.4 Recent Developments
12.13. Sharp Services LLC
- 12.13.1 Company Overview
- 12.13.2 Company Revenue
- 12.13.3 Products
- 12.13.4 Recent Developments
12.14. Thermo Fisher Scientific Inc.
- 12.14.1 Company Overview
- 12.14.2 Company Revenue
- 12.14.3 Products
- 12.14.4 Recent Developments
12.15. Worldwide Clinical Trials
- 12.15.1 Company Overview
- 12.15.2 Company Revenue
- 12.15.3 Products
- 12.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies